Publications by authors named "Lisa M Ebert"

27Publications

Platelets disrupt vasculogenic mimicry by cancer cells.

Sci Rep 2020 04 3;10(1):5869. Epub 2020 Apr 3.

Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-020-62648-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125143PMC
April 2020

DeepSurvNet: deep survival convolutional network for brain cancer survival rate classification based on histopathological images.

Med Biol Eng Comput 2020 May 2;58(5):1031-1045. Epub 2020 Mar 2.

Centre for Cancer Biology, SA Pathology and University of South Australia, UniSA CRI Building, North Terrace, Adelaide, SA, 5001, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11517-020-02147-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188709PMC
May 2020

Clinical chimeric antigen receptor-T cell therapy: a new and promising treatment modality for glioblastoma.

Clin Transl Immunology 2019 20;8(5):e1050. Epub 2019 May 20.

Translational Oncology Laboratory Centre for Cancer Biology University of South Australia and SA Pathology Adelaide SA Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cti2.1050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526894PMC
May 2019

Optimization of manufacturing conditions for chimeric antigen receptor T cells to favor cells with a central memory phenotype.

Cytotherapy 2019 06 8;21(6):593-602. Epub 2019 Apr 8.

Translational Oncology Laboratory, Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia; Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia; School of Medicine, the University of Adelaide, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2019.03.003DOI Listing
June 2019

Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments.

Biochem Soc Trans 2019 04 22;47(2):625-638. Epub 2019 Mar 22.

Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia

View Article

Download full-text PDF

Source
http://www.biochemsoctrans.org/lookup/doi/10.1042/BST2018044
Publisher Site
http://dx.doi.org/10.1042/BST20180444DOI Listing
April 2019

Logic-gated approaches to extend the utility of chimeric antigen receptor T-cell technology.

Biochem Soc Trans 2018 04 14;46(2):391-401. Epub 2018 Mar 14.

Translational Oncology Laboratory, Centre for Cancer Biology, University of South Australia and SA Pathology, Frome Road, Adelaide, SA 5000, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/BST20170178DOI Listing
April 2018

Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?

Clin Transl Immunology 2017 Mar 17;6(3):e134. Epub 2017 Mar 17.

Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cti.2017.7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382436PMC
March 2017

Interleukin-3 greatly expands non-adherent endothelial forming cells with pro-angiogenic properties.

Stem Cell Res 2015 May 9;14(3):380-95. Epub 2015 Apr 9.

Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, South Australia, Australia; Co-operative Research Centre for Biomarker Translation, La Trobe University, Melbourne, Victoria, Australia; School of Medicine, University of Adelaide, Adelaide, South Australia, Australia; Centre for Stem Cell Research, Robinson Institute, University of Adelaide, Adelaide, South Australia, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2015.04.002DOI Listing
May 2015

Fos-icking for control of angiogenesis: increasing the longevity of peritoneal dialysis.

Kidney Int 2013 Dec;84(6):1065-7

1] Centre for Cancer Biology, SA Pathology, Adelaide, South Australia, Australia [2] School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia [3] School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2013.306DOI Listing
December 2013

Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects.

Eur J Immunol 2013 Feb 5;43(2):533-9. Epub 2012 Dec 5.

Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201242603DOI Listing
February 2013

A novel method for detecting antigen-specific human regulatory T cells.

J Immunol Methods 2012 Mar 13;377(1-2):56-61. Epub 2012 Jan 13.

Ludwig Institute for Cancer Research (Melbourne-Austin Branch), Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2012.01.004DOI Listing
March 2012

Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma.

Clin Cancer Res 2009 Mar 10;15(6):2166-73. Epub 2009 Mar 10.

Ludwig Institute for Cancer Research, Austin Health, Peter MacCallum Cancer Centre, CSL Limited, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2484DOI Listing
March 2009

A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design.

Cancer Res 2009 Feb 27;69(3):1046-54. Epub 2009 Jan 27.

Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, Austin Health, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-2926DOI Listing
February 2009

The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.

Cancer Res 2008 Apr;68(8):3001-9

Ludwig Institute for Cancer Research (Melbourne Center for Clinical Sciences), Austin Health, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-5664DOI Listing
April 2008

Comment on "The vast majority of CLA+ T cells are resident in normal skin".

J Immunol 2006 Aug;177(3):1375-6; author reply 1376-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.177.3.1375DOI Listing
August 2006

Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance.

J Immunol 2006 Apr;176(7):4331-6

Institute of Cell Biology, University of Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.176.7.4331DOI Listing
April 2006

Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation.

Immunity 2005 Sep;23(3):331-42

Institute of Cell Biology, University of Bern, CH-3012 Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2005.08.012DOI Listing
September 2005

Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.

Mol Immunol 2005 May 23;42(7):799-809. Epub 2004 Nov 23.

Theodor-Kocher Institute, University of Bern, Freiestrasse 1, CH-3012 Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2004.06.040DOI Listing
May 2005

B cells alter the phenotype and function of follicular-homing CXCR5+ T cells.

Eur J Immunol 2004 Dec;34(12):3562-71

Theodor-Kocher Institute, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.200425478DOI Listing
December 2004

Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytes.

J Immunol 2002 Jan;168(1):65-72

Chemokine Biology Laboratory, Department of Molecular Biosciences, Adelaide University, Adelaide 5005, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.168.1.65DOI Listing
January 2002